Carmine Sellitto is an MD specialist in Clinical Pharmacology and Toxicology. He is currently attending the PhD in Translational Medicine of Development and Active Aging at the University of Salerno. He belongs to the Department of Medicine, Surgery and Dentistry of the same University and works at the Clinical Pharmacology and Pharmacogenetic Unit of the University Hospital of Salerno. He carries out an intense research activity in the field of pharmacology, pharmacogenetics, physical activity in athletes and oxidative stress.
Healthcare innovation can be pursued by spreading disciplines that allow the achievement of precision medicine. One of them is Clinical Pharmacology which guarantees in the National Health Service (NHS) the correct use of drugs according with individual patient's response. The skills of the Clinical Pharmacologist, encompassing pharmacodynamics, pharmacokinetics, pharmacogenetics, pharmacoepidemiology, toxicology and pharmacovigilance, allow a safe and appropriate use of the drug, also in very complex patients. Clinical Pharmacology aims to safeguard prescriptive appropriateness respecting the risk/benefit and cost/benefit assessments, improving the clinical practice. It can support primary care by helping in setting up the treatments by therapy reconciliation and deprescribing processes. Indeed, thanks to deep knowledge in old and new drugs, the Clinical Pharmacologist can lend his expertise for diagnostic, therapeutic and assistance activities aimed at constantly improving the drug safety, assessed specifically for each individual patient. In addition, the Clinical Pharmacology is essential for the design, management, and monitoring of clinical trials, in all their phases, contributing to strategic progresses of the NHS in step with times. Clinical Pharmacology is essential to improve clinical practice, to create truly personalized medicine and to improve clinical and healthcare outcomes
Andrzej Kuszka MD. Chefarzt Gynäkologie/ Head of Gynecology and Obsterics bei Die Klinik in Preetz. Die Klinik in PreetzRuprecht-Karls-Universität Heidelberg
Regarding the etiology of female stress urine incontinence (SUI) one important parameter is a lack of support function for bladder and urethra by pelvic floor, caused by the structure of connective tissue in endopelvic fascia.(1) Despite the benefit of mesh or sling, some patients will not accept (fear of surgery, lighter cases f SUI ). The non-invasive micro hyperthermia by laser is a promising new therapeutic option. (2,3) Being conducted between 2016 and 2019 , our prospective study (4) aimed the mid-term results (24 month) of laser treatment according to the severity of SUI. Fifty-nine women, 32 mild (SUI I), 16 moderate (SUI II) and 11 severe (SUI III) cases were included. Laser therapy was performed with Erbium:YAG laser (Fotona) following the IncontiLase® protocol (5). Patients received 5 laser treatments, one at baseline, and one at 1, 2, 3 and 4 months. Objective (pad test) and subjective data (ICIQ-UI SF and PISQ-12 questionnaires) were assessed at baseline, 1 month after the 2nd session, 6 months and 2 years after the 5th session.
Dr. BAJRANGI YADAV, Assistant Professor of PSYCHOLOGY, K.N.I., Sultanpur (U.P.), India.
The Coronavirus Disease 2019 (COVID-19) pandemic has deeply altered social and working environments in several ways. Social distancing policies, mandatory lockdowns, isolation periods, and anxiety of getting sick, along with the suspension of productive activity, loss of income, and fear of the future, jointly influence the mental health of citizens and workers. Workplace aspects can play a crucial role on moderating or worsening mental health of people facing this pandemic scenario. The purpose of this literature review is to deepen the psychological aspects linked to workplace factors, following the epidemic rise of COVID-19, in order to address upcoming psychological critical issues in the workplaces. We performed a literature search using Google Scholar, PubMed, and Scopus, selecting papers focusing on workers’ psychological problems that can be related to the workplace during the pandemic. Thirty-five articles were included. Mental issues related to the health emergency, such as anxiety, depression, post-traumatic stress disorder (PTSD), and sleep disorders are more likely to affect healthcare workers, especially those on the frontline, migrant workers, and workers in contact with the public.
Ashish Kaushal. Senior General Manager at Zydus Group. Zydus GroupIndian Institute of Management, Ahmedabad. Mumbai, Maharashtra, India.
Aarogyapath, a web-based solution for the healthcare supply chain that provides real-time availability of critical supplies launched. This public platform will help healthcare users like hospitals, pathology laboratories, research institutes, medical colleges and patients. This national healthcare supply chain portal will remove supply chain bottlenecks during the Covid-19 pandemic. The vision of this initiative is to set up an information management and forecasting database platform at national level. It will capture demand and supply scenarios for key healthcare needs items. This public platform can help customers in tackling a number of routinely experienced issues like dependence on limited suppliers, time-consuming processes to identify good quality products, limited access to suppliers etc. It also helps to reduce the Black Marketing of medical equipment & products, Unstandardized Medical product prices. It’s the single platform of all medical suppliers & buyers for any announcement/feedback etc. It will also help the manufacturers and suppliers to reach customers efficiently like nearby pathological laboratories, medical stores, hospitals, etc. It will also create opportunities for business.
Sabrina Luthfa has her expertise in the field of innovation management and entrepreneurship. Her research interest lies in exploring innovation ecosystem and its evolution in different context of innovation. Currently she is working as a senior lecturer in the University West, Sweden.
The purpose of the study is to understand how healthcare service innovation process is managed in the publicly funded healthcare sector. A qualitative study has been done in the healthcare sector in Sweden at Västra Götaland municipal level. From five in-depth interviews the study suggests that an intermediary organization like testbed plays a crucial role in enabling innovation (new service development) in the healthcare service sector in Sweden as it creates a context where the private sector (companies) meet with their match in the public sector such as, healthcare service provider, academic researchers, and municipality. Testbed allows these different actors to place their offers in the table for achieving a common goal thus enable new service creation. However, testbed fails to enable the diffusion of the new service due to (1) regulatory issues which often evolves simultaneously with the new service production over time and (2) organizational resistance to change which often is associated with the fear of replacing the employees with new machines or new ways of treating patients thus considered as socially unsustainable.